Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,718,643

« Back to Dashboard

Title:Pharmaceutical formulation
Abstract: The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
Inventor(s): Cho; Wing-Kee Philip (Princeton, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Filing Date:May 26, 2009
Application Number:12/472,021
Claims:1. A pharmaceutical composition comprising: (a) from 1% to 20% by weight of a cholesterol absorption inhibitor; (b) from 1% to 80% by weight of at least one HMG-CoA reductase inhibitor; (c) from 0.005% to 10% by weight of ascorbic acid; (d) croscarmellose sodium; and (e) povidone.

2. The pharmaceutical composition according to claim 1, wherein the cholesterol absorption inhibitor is ezetimibe.

3. The pharmaceutical composition according to claim 1, wherein the HMG-Co-A reductase inhibitor is simvastatin or atorvastatin.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.